https://www.marketscreener.com/quote/stock/PELOTON-THERAPEUTICS-INC-58808515/news/Peloton-Therapeutics-Inc-Initiates-Patient-Dosing-in-Phase-2-Study-of-PT2385-for-Von-Hippel-Lindau-35099279/?utm_source=telegram&utm_medium=social&utm_campaign=share